Acute Dyspnea
Conditions
Keywords
acute dyspnea, acute heart failure, emergency
Brief summary
This is an observational prospective multicenter study of patients admitted for acute dyspnea in an emergency department of the participating centers in the Lorraine district. The primary objective is to assess the outcome of this population according to the cause of acute dyspnea as well as identify the predictors of this outcome, both overall and according to each acute dyspnea cause.
Detailed description
This observational prospective multicenter study will be conducted using data from electronic medical records, acquired as part of usual care, in patients admitted for acute dyspnea in the emergency department. Clinical, treatment, laboratory and imaging data acquired during the hospitalization (in the emergency department and in the department that admitted the patients following the emergency department stay) will be collected. Vital status will be recorded at 30 days and 1 year post-admission.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Men or women \> or = 18 years. * Patients with acute dyspnea admitted for acute dyspnea in the emergency department. * Patient informed.
Exclusion criteria
* Cardiorespiratory arrest. * Patient having expressed his or her opposition.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All cause mortality | From emergency admission for acute dyspnea up until 1 year |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Clinical data | through hospital stay, an average of 10 days | — |
| Treatment data | through hospital stay, an average of 10 days | — |
| Laboratory data | through hospital stay, an average of 10 days | — |
| Imaging data | through hospital stay, an average of 10 days | — |
| Duration of hospitalization | At final discharge, an average of 10 days after admission | including emergency stay and conventional hospitalization |
| Initial diagnosis in the emergency department | At admission | — |
| Final diagnosis of the initial hospitalization stay | At final discharge, an average of 10 days after admission | — |
| Brain Natriuretic Peptide | Through hospital stay, an average of 10 days | — |
| Estimated glomerular function rate | Through hospital stay, an average of 10 days | — |
| Estimated plasma volume | Through hospital stay, an average of 10 days | — |
| Demographic data | through hospital stay, an average of 10 days | — |
| Urea | Through hospital stay, an average of 10 days | — |
| Use of non-invasive ventilation | Through hospital stay, an average of 10 days | — |
| Time of use of non-invasive ventilation | Through hospital stay, an average of 10 days | — |
| Use of diuretics | Through hospital stay, an average of 10 days | — |
| Time of use of diuretics | Through hospital stay, an average of 10 days | — |
| Use of nitrates | Through hospital stay, an average of 10 days | — |
| Time of use of nitrates | Through hospital stay, an average of 10 days | — |
| Department type admitting the patient following emergency management | Through hospital stay, an average of 10 days | intensive care unit, cardiology, cardiac intensive care unit, other ... |
| All cause in-hospital mortality | At final discharge, an average of 10 days after admission | — |
| Liver biological biomarkers | Through hospital stay, an average of 10 days | — |
Countries
France